Estados Unidos · Plataformas y datos · The Motley Fool

CME vs. Nu: Which Financial Stock Is a Better Buy for 2027?

Publicado por The Motley Fool · Estados Unidos hace 1 h

CME boasts a 62% net margin and fortress balance sheet, while Nu's 43% revenue growth signals emerging-market momentum, but their risk profiles diverge sharply.

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

CME vs. Nu: Which Financial Stock Is a Better Buy for 2027?

También te puede interesar

Treasury yields fall after Democrats win House and Senate majorities

CVS Health plans to split in two. Here’s what is driving the massive healthcare breakup.

Best Stocks Under $5

CS Disco LLC earnings missed by $0.06, revenue topped estimates

Market News

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5

CME vs. Nu: Which Financial Stock Is a Better Buy for 2027?

Compartir

También te puede interesar

Treasury yields fall after Democrats win House and Senate majorities

CVS Health plans to split in two. Here’s what is driving the massive healthcare breakup.

Best Stocks Under $5

CS Disco LLC earnings missed by $0.06, revenue topped estimates

Market News

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5